DALS | DA32 Life Science Tech Acquisition Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	10.29 - 10.32
52 Week Range	9.68 - 11.22
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	2,248
Average Volume	29,061
Shares Outstanding	25,650,000
Market Cap	264,195,000
Sector	Financial Services
Industry	Shell Companies
IPO Date	2021-07-28

Valuation
Profitability
Growth
Health
P/E Ratio	171.67
Forward P/E Ratio	N/A
EPS	0.06
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	USA

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

DALS's peers: CSLM, CNDA, ADRT

*Chart delayed

Analyzing fundamentals for DALS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see DALS Fundamentals page.

Watching at DALS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on DALS Technicals page.